Solesence (NASDAQ:SLSN – Get Free Report) is one of 55 publicly-traded companies in the “Personal Care Products” industry, but how does it contrast to its competitors? We will compare Solesence to related companies based on the strength of its institutional ownership, valuation, dividends, profitability, risk, earnings and analyst recommendations.
Analyst Recommendations
This is a summary of recent recommendations and price targets for Solesence and its competitors, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Solesence | 1 | 0 | 0 | 0 | 1.00 |
| Solesence Competitors | 835 | 2796 | 3568 | 212 | 2.43 |
As a group, “Personal Care Products” companies have a potential upside of 4.49%. Given Solesence’s competitors stronger consensus rating and higher possible upside, analysts clearly believe Solesence has less favorable growth aspects than its competitors.
Earnings and Valuation
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Solesence | $62.06 million | $1.79 million | 101.90 |
| Solesence Competitors | $7.89 billion | $1.08 billion | 2.38 |
Solesence’s competitors have higher revenue and earnings than Solesence. Solesence is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Volatility & Risk
Solesence has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500. Comparatively, Solesence’s competitors have a beta of 0.79, meaning that their average share price is 21% less volatile than the S&P 500.
Profitability
This table compares Solesence and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Solesence | 1.56% | 5.39% | 1.78% |
| Solesence Competitors | -6.19% | -113.37% | -0.20% |
Institutional and Insider Ownership
70.2% of Solesence shares are held by institutional investors. Comparatively, 49.0% of shares of all “Personal Care Products” companies are held by institutional investors. 4.8% of Solesence shares are held by insiders. Comparatively, 12.5% of shares of all “Personal Care Products” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Solesence competitors beat Solesence on 7 of the 13 factors compared.
Solesence Company Profile
Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications. The company was incorporated in 1989 and is headquartered in Romeoville, Illinois.
Receive News & Ratings for Solesence Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solesence and related companies with MarketBeat.com's FREE daily email newsletter.
